Clinical Trials on Glabellar Crease in United Kingdom
Total 7462 results
-
Otsuka Novel Products GmbHTerminatedBreast Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Salivary Gland Cancer | Squamous Cell Carcinoma of the CervixUnited Kingdom
-
Institut de Recherches Internationales ServierBreast International GroupCompletedBreast CancerUnited Kingdom, Italy, France, Belgium, Australia, Canada, Germany, Hungary, Spain
-
Novartis PharmaceuticalsCompletedAdvanced HER2-positive Breast Cancer or Gastric CancerTaiwan, Netherlands, Italy, United States, Belgium, United Kingdom, Korea, Republic of, France, Spain
-
Merck Sharp & Dohme LLCDaiichi SankyoRecruitingBreast Cancer | Breast NeoplasmsUnited States, Israel, United Kingdom, Canada, Japan, South Korea
-
AstraZenecaCompletedFGFR Inhibition, Pharmacokinetics, Biomarkers | ER+ Breast CancerCzech Republic, Italy, United Kingdom, Hungary, Germany, Romania, Belgium, France
-
Novartis PharmaceuticalsTerminatedMetastatic Breast Cancer | HER2+ Breast CancerBelgium, France, Spain, United States, United Kingdom, Italy
-
BioNTech SEBristol-Myers SquibbActive, not recruitingTriple Negative Breast Cancer | Locally Advanced Breast Cancer | Metastatic Triple Negative Breast CancersUnited States, United Kingdom, Australia, Turkey (Türkiye)
-
Hoffmann-La RocheTerminatedTriple Negative Breast Cancer | Advanced Ovarian CancerUnited Kingdom, United States, Australia, Denmark, Canada
-
Eli Lilly and CompanyCompletedBreast CancerUnited States, Belgium, Spain, Germany, United Kingdom, France
-
Crown Laboratories, Inc.CompletedIchthyosis VulgarisUnited States
-
Eli Lilly and CompanyCompletedBreast CancerArgentina, Belgium, Germany, Romania, Spain, United Kingdom
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeTerminatedMelanoma | Soft Tissue Sarcoma | Renal Cell Carcinoma | Cervical Cancer | Breast Cancer | Small Cell Lung Cancer | Glioblastoma | Pancreatic Cancer | Ovarian Cancer | Non-small Cell Lung Cancer | Gastrointestinal CancerUnited Kingdom
-
BayerCompletedBreast Neoplasms | Breast Cancer, MetastaticFrance, Germany, Spain, Austria, Belgium, Slovenia, Poland, Bulgaria, United Kingdom, Italy
-
Eisai LimitedTerminatedMetastatic Breast CancerRussian Federation, United Kingdom, Germany, Italy, Spain
-
Boehringer IngelheimCompletedBreast NeoplasmsHong Kong, Taiwan, United Kingdom, Russian Federation, India, Poland
-
University of SunderlandUniversity of GlasgowNot yet recruitingCervical Cancer | Breast Cancer | Bowel Cancer | Abdominal Aortic AneurysmUnited Kingdom
-
Ayala Pharmaceuticals, Inc,TerminatedTriple Negative Breast CancerUnited States, Belgium, Israel, Spain, United Kingdom
-
ETOP IBCSG Partners FoundationCompletedBreast Cancer | Fatigue | Cognitive/Functional Effects | Psychosocial Effects of Cancer and Its TreatmentBelgium, Switzerland, United Kingdom, Australia, Italy, New Zealand
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Spain, Israel, Canada, Belgium, United Kingdom, France, Tunisia
-
Hoffmann-La RocheTerminatedBreast CancerUnited States, Brazil, Australia, Canada, Japan, Korea, Republic of, Spain, United Kingdom
-
Scancell LtdRecruitingSquamous Cell Carcinoma of the Head and Neck | Triple Negative Breast Cancer | Renal Cell Cancer | High Grade Ovarian Serous AdenocarcinomaUnited Kingdom
-
BayerCompletedBreast Neoplasms | Breast Cancer, MetastaticGermany, Italy, Israel, Poland, Switzerland, United Kingdom, Greece
-
Patagonia Pharmaceuticals, LLCCompletedCongenital IchthyosisUnited States
-
Cambridge University Hospitals NHS Foundation TrustAstraZeneca; Cancer Research UKRecruiting
-
European Organisation for Research and Treatment...CompletedBreast CancerItaly, Spain, Belgium, Jordan, Poland, United Kingdom, Netherlands, France, Germany, Switzerland
-
Bristol-Myers SquibbCompletedBreast CancerCzech Republic, United States, Spain, United Kingdom, Ireland, Poland, France, Sweden
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Israel, Spain, Australia, Canada, New Zealand, United Kingdom, France, Tunisia
-
Novartis PharmaceuticalsTerminatedBreast CancerFrance, Canada, United Kingdom, Germany, Italy, United States
-
PfizerCompletedBreast NeoplasmsNetherlands, United States, United Kingdom, Germany, Italy
-
European Organisation for Research and Treatment...ALMANAC Trialists Group; Borstkanker Onderzoeksgroup NederlandCompletedBreast CancerNetherlands, United Kingdom, France, Switzerland, Italy, Slovenia, Poland, Turkey
-
Synta Pharmaceuticals Corp.CompletedBreast Cancer | Triple Negative Breast Cancer | HER-2 Positive Breast Cancer | ER/Progressive Response (PR) + Refractory to Prior Hormonal TreatmentSpain, United States, Argentina, Belgium, Brazil, Korea, Republic of, Peru, United Kingdom
-
MedSIRRecruitingBreast CancerSpain, United Kingdom
-
Cancer Research Campaign Clinical Trials CentreCompletedLymphoma | Testicular Germ Cell Tumor | Breast Cancer | Small Intestine Cancer | Ovarian Cancer | Lung Cancer | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Infection | Extragonadal Germ Cell TumorUnited Kingdom
-
European Organisation for Research and Treatment...Hoffmann-La RocheCompletedElderly Metastatic Breast Cancer PopulationBelgium, Italy, Netherlands, France, Poland, United Kingdom, Portugal, Sweden
-
German Breast GroupPfizer; AGO Study Group; Breast International Group; NSABP Foundation IncCompletedBreast Cancer | Hormonreceptor Positive | Her2-normal | Postneoadjuvant Treatment With CDK 4/6 Inhibitor | CPS-EG ScoreUnited States, Australia, Austria, Canada, France, Germany, Ireland, Japan, Korea, Republic of, Spain, United Kingdom
-
Astellas Pharma IncCompletedBreast CancerUnited States, Ireland, Belgium, Czech Republic, Germany, Poland, Russian Federation, United Kingdom
-
PfizerTerminatedTriple Negative Breast NeoplasmsSpain, United Kingdom, United States, Italy, Hungary, Poland
-
Royal Marsden NHS Foundation TrustPfizer; AstraZeneca; Institute of Cancer Research, United Kingdom; UNICANCER; Gustave... and other collaboratorsRecruitingHER2-negative Breast Cancer | ER+ Breast CancerUnited Kingdom, France
-
Immutep S.A.S.CompletedAdenocarcinoma Breast Stage IVNetherlands, United Kingdom, France, Belgium, Germany, Hungary, Poland
-
R-PharmCompletedMetastatic Breast CancerItaly, United Kingdom, United States, France, Spain
-
The Christie NHS Foundation TrustUnknownSarcoma | Cervical Cancer | Breast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Prostate Cancer | Vulvar Cancer | Endometrial Cancer | Vaginal Cancer | Primary Peritoneal Cavity CancerUnited Kingdom
-
AstraZenecaActive, not recruitingTriple Negative Breast NeoplasmsUnited States, Canada, Taiwan, United Kingdom, Poland, South Korea
-
Novartis PharmaceuticalsActive, not recruitingBreast CancerUnited States, United Kingdom, France, Australia, Switzerland, Italy, Spain, South Korea
-
SanofiTerminatedBreast CancerBelgium, Spain, Canada, France, United Kingdom, Czechia, United States, Italy, Poland, Portugal
-
SanofiCancer International Research Group (CIRG)CompletedBreast CancerUnited States, France, Canada, Brazil, Poland, Germany, Portugal, Spain, Sweden, Slovakia, Czech Republic, Uruguay, Argentina, Egypt, Hungary, Israel, South Africa, Austria, Greece, United Kingdom
-
BioNTech SEDualityBio Inc.; BioNTech (Shanghai) Pharmaceuticals Co., Ltd.RecruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast CarcinomaUnited States, France, China, United Kingdom, Canada, Georgia, Italy, Turkey (Türkiye), Moldova
-
AstraZenecaCompletedMetastatic Breast CancerItaly, United Kingdom, Brazil, Czechia, Poland, United States, Spain, Bulgaria, France
-
Hoffmann-La RocheRecruitingBreast CancerSpain, United Kingdom, Belgium, Finland, Denmark, Germany, Italy, Norway
-
LifeCellTerminatedMastectomy and Breast ReconstructionFrance, Germany, United Kingdom
-
Eisai Inc.CompletedBreast Cancer | Breast Neoplasms | Cancer, Breast | Breast Cancer Female | Estrogen Receptor Positive Tumor | Breast Adenocarcinoma | ER Positive | Estrogen-receptor Positive Breast CancerFrance, United Kingdom, United States